This podcast is a follow-up to the October webinar, A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond. Our experts will address audience questions that they were unable to answer during the webinar.
Stephen Eckel, PharmD, MHA, BCPS is Associate Director of Pharmacy and Director, Pharmacy Residency Programs at UNC Hospitals in Chapel Hill, North Carolina. Dr. Eckel is also Clinical Associate Professor and Vice Chair, Graduate and Post-Graduate Education in the division of practice advancement and clinical education at the University of North Carolina Eshelman School of Pharmacy.
Dr. Eckel is known as an innovator and entrepreneur within the pharmacy profession. He conducts and publishes research related to safe handling of hazardous drugs among other topics and is frequently asked to speak around the world on these issues.
AnnMarie Lee Walton, PhD, MPH, RN, OCN, CHES, FAAN is an Associate Professor at the Duke University School of Nursing. Dr. Walton conducts research to understand and minimize antineoplastic drug exposure for healthcare workers. Dr. Walton has promoted legislative efforts to mandate safer handling of hazardous drugs and received the 2016 Oncology Nursing Society (ONS) Excellence in Health Policy and Advocacy Award. She is a content expert on safe handling projects and co-led the ONS/Hematology/Oncology Pharmacist Association (HOPA) joint position statement on safe handling of hazardous drugs and is the co-editor of the forthcoming ONS Safe Handling Text.
Amy Holmes, PharmD, BCPPS is a Director of Scientific Projects at ASHP where she works with members to create educational content for webinars, podcasts, board certification products, and national meetings.
Relevant Financial Relationship Disclosures
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.